Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: J ECT. 2013 Mar;29(1):3–12. doi: 10.1097/YCT.0b013e31826ea8c4

Table 5. Average and Maximum UKU Score During the Continuation Trial as a Function of Clinical Outcome.

Phase 2 Outcome Average UKU Score Maximum UKU Score
Mean SD Mean SD
Completed without relapse (N=40) 7.73 3.83 13.53 5.35
Relapse (N=59) 15.69 7.28 20.93 7.04
Dropout (N=15) 11.76 6.82 15.80 7.40

Note. UKU data were not obtained in 8 patients.